Bank of Montreal Can Buys 558,689 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Bank of Montreal Can boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 365.6% in the third quarter, Holdings Channel reports. The firm owned 711,487 shares of the company’s stock after purchasing an additional 558,689 shares during the quarter. Bank of Montreal Can’s holdings in Henry Schein were worth $52,095,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. ING Groep NV acquired a new position in shares of Henry Schein in the 3rd quarter valued at approximately $63,226,000. Thompson Siegel & Walmsley LLC acquired a new position in Henry Schein during the second quarter valued at approximately $46,683,000. SG Americas Securities LLC lifted its stake in Henry Schein by 1,622.3% during the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Finally, Private Management Group Inc. acquired a new stake in shares of Henry Schein in the 3rd quarter valued at $24,176,000. Institutional investors own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HSIC. Robert W. Baird lowered their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Barrington Research reiterated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, UBS Group cut their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Price Performance

HSIC stock opened at $77.66 on Thursday. The company has a market capitalization of $9.68 billion, a P/E ratio of 31.96, a PEG ratio of 2.20 and a beta of 0.87. The company has a fifty day moving average price of $71.15 and a 200-day moving average price of $69.78. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the company earned $1.32 EPS. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, equities analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.